NMDA receptor signaling induces the chemoresistance of temozolomide via upregulation of MGMT expression in glioblastoma cells

被引：0
|
作者：
Shohei Tsuji
Shinsuke Nakamura
Kenji Shoda
Tetsuya Yamada
Masamitsu Shimazawa
Noriyuki Nakayama
Toru Iwama
Hideaki Hara
机构：
[1] Gifu Pharmaceutical University,Molecular Pharmacology, Department of Biofunctional Evaluation
[2] Gifu University Graduate School of Medicine,Department of Neurosurgery
[3] Gifu Pharmaceutical University,Lab. Of Collaborative Research for Innovative Drug Discovery
来源：
Journal of Neuro-Oncology | 2022年 / 160卷
关键词：
-methyl-D-aspartate receptor; Glioblastoma; O; -methylguanine DNA methyltransferase; Memantine; Temozolomide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：375 / 388
页数：13
相关论文
共 50 条
  • [21] A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma
    Chen, Xiaoyue
    Zhang, Minjie
    Gan, Haiyun
    Wang, Heping
    Lee, Jeong-Heon
    Fang, Dong
    Kitange, Gaspar J.
    He, Lihong
    Hu, Zeng
    Parney, Ian F.
    Meyer, Fredric B.
    Giannini, Caterina
    Sarkaria, Jann N.
    Zhang, Zhiguo
    NATURE COMMUNICATIONS, 2018, 9
  • [22] Role of miR-223/paired box 6 signaling in temozolomide chemoresistance in glioblastoma multiforme cells
    Cheng, Quan
    Ma, Xiaoqiang
    Cao, Hui
    Chen, Zigui
    Wan, Xin
    Chen, Rui
    Peng, Renjun
    Huang, Jun
    Jiang, Bing
    MOLECULAR MEDICINE REPORTS, 2017, 15 (02) : 597 - 604
  • [23] Oct-3/4 induces CpG demethylation in the MGMT promoter to induce temozolomide resistance in glioblastoma cells
    Takahashi, Hisaaki
    Kobayashi, Yukako
    Sugimoto, Kana
    Yano, Hajime
    Tanaka, Junya
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2013, 63 : S201 - S201
  • [24] MIRNA EXPRESSION, MGMT PROTEIN EXPRESSION AND RESPONSE TO TEMOZOLOMIDE-BASED CHEMOTHERAPY IN GLIOBLASTOMA
    Cipriani, D.
    NEURO-ONCOLOGY, 2016, 18 : 30 - 30
  • [25] Effect of lomeguatrib-temozolomide combination on MGMT promoter methylation and expression in primary glioblastoma tumor cells
    Taspinar, Mehmet
    Ilgaz, Seda
    Ozdemir, Mevci
    Ozkan, Tulin
    Oztuna, Derya
    Canpinar, Hande
    Rey, Juan A.
    Sunguroglu, Asuman
    Castresana, Javier S.
    Ugur, Hasan Caglar
    TUMOR BIOLOGY, 2013, 34 (03) : 1935 - 1947
  • [26] TOP2A is implicated in chemoresistance to temozolomide in glioblastoma cells.
    Fukushima, Tsuyoshi
    Yamashita, Fumiki
    Kawaguchi, Makiko
    Yamamoto, Koji
    Tanaka, Hiroyuki
    Kataoka, Hiroaki
    CANCER SCIENCE, 2022, 113 : 1741 - 1741
  • [27] Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells
    Munoz, Jessian L.
    Walker, Nykia D.
    Scotto, Kathleen W.
    Rameshwar, Pranela
    CANCER LETTERS, 2015, 367 (01) : 69 - 75
  • [28] Metastasis-enhancing protein KITENIN confers temozolomide resistance in glioblastoma with unmethylated MGMT via upregulation of cancer stem cell makers
    Ahn, Eun-Jeong
    Kim, Yeong Jin
    Jung, Tae-Young
    Lee, Jae-Hyuk
    Rhee, Joon Haeng
    Kim, Kyung-Keun
    Kim, Sung Sun
    Kim, Nah Ihm
    Kim, Hangun
    Moon, Kyung-Sub
    Lee, Kyung-Hwa
    CANCER RESEARCH, 2024, 84 (06)
  • [29] Pyrvinium pamoate regulates MGMT expression through suppressing the Wnt/β-catenin signaling pathway to enhance the glioblastoma sensitivity to temozolomide
    Haisong Li
    Shuhan Liu
    Rihua Jin
    Haiyang Xu
    Yunqian Li
    Yong Chen
    Gang Zhao
    Cell Death Discovery, 7
  • [30] Metastasis-enhancing protein KITENIN confers temozolomide resistance on glioblastoma with unmethylated MGMT via upregulation of cancer stem cell makers
    Ahn, Eun-Jung
    Kim, Yeong Jin
    Akanda, Md Rashedunnabi
    Oh, Se-Jeong
    Jung, Tae-Young
    Jung, Shin
    Lee, Jae-Hyuk
    Kim, Sung Sun
    Jeong, Yong Yeon
    Ha, Hyung-Ho
    Hyun, Hoon
    Kim, Hangun
    Rhee, Joon Haeng
    Kim, Kyung Keun
    Lee, Kyung-Hwa
    Moon, Kyung-Sub
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (08):
12345